Anticolitic Effect of Berberine in Rat Experimental Model: Impact of PGE2/p38 MAPK Pathways

Mediators of Inflammation - Tập 2020 - Trang 1-12 - 2020
Jia Li1, Kuijin Xue2, Junheng Liu2, Ola A. Habotta3, Lianhai Hu4, Ahmed E. Abdel Moneim5, Daniela Caccamo
1Department of Gastroenterology, Maternal and Child Health Care Hospital of Shandong Province, Jinan 251400, China
2Department of Gastroenterology, The Affiliated Hospital of Qingdao University, Qingdao City 266000, China
3Department of Forensic Medicine and Toxicology, Faculty of Veterinary Medicine, Mansoura University, Mansoura 35516, Egypt
4Department of Traditional Chinese Medicine, Qilu Hospital, Cheeloo College of Medicine, Shandong University, No. 107 Wenhuaxi Road, Jinan, Shandong Province 250012, China
5Department of Zoology and Entomology, Faculty of Science, Helwan University, Cairo 11795, Egypt

Tóm tắt

Berberine (BER), a natural isoquinoline alkaloid, has been demonstrated to have appreciable anticolitis effects. Nevertheless, the protective mechanism of BER in ulcerative colitis (UC) is barely understood. The present study was aimed at exploring the therapeutic efficacy of BER on UC in experimental colitis rat model. Rats were orally administered with BER for seven days at low and high doses (25 and 50 mg/kg/day) before AcOH intracolonic instillation. BER significantly retrieved colon inflammation and mucosal damage indicated by inhibition of macroscopic score and lessened the levels of inflammatory biomarkers (IL-1β, IL-6, TNF-α, MPO, and PGE2). Notable downregulation of mRNA expression of p38 MAPK and increased protein expression of TGF-β were achieved by BER treatment. The anti-inflammatory potential of BER was supported by the histopathological screening of colon mucosa. In addition, BER restored colonic antioxidant capacity through elevation of GSH level and antioxidant enzymatic activities (SOD, CAT, GPx, and GR) together with reductions of both MDA and NO levels. Marked downregulation of Nos2 mRNA expression is accompanied by increased Nrf2 and Hmox-1 expressions in colon specimens treated by BER. Furthermore, BER exhibited noticeable antiapoptotic activities through decreasing proapoptotic proteins (Bax and caspase-3) and lessening antiapoptotic Bcl-2 protein in the colon mucosa. Based on these findings, BER may improve colitis markedly which may be mediated by its striking antioxidant, anti-inflammatory, and antiapoptotic properties.

Từ khóa


Tài liệu tham khảo

10.1016/j.fct.2018.03.002

10.1016/j.ejphar.2019.172456

10.1016/j.ejphar.2019.02.021

Okuyama, 2012, Multicenter prospective study for clinical and endoscopic efficacies of leukocytapheresis therapy in patients with ulcerative colitis, Scandinavian Journal of Gastroenterology, 48, 412, 10.3109/00365521.2012.763175

10.1016/j.biopha.2018.04.071

10.1007/s10620-014-3478-7

10.3748/wjg.v19.i34.5633

10.1016/j.jep.2015.03.027

10.1155/2019/6138723

10.1007/s11011-015-9652-6

10.3892/etm.2017.4402

10.1016/j.apsb.2019.08.006

Zhang, 2012, Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats, PLoS One, 7

10.1152/ajpgi.00312.2011

10.1016/j.intimp.2018.12.036

10.1371/journal.pone.0182464

Lowry, 1951, Protein measurement with the Folin phenol reagent, The Journal of Biological Chemistry, 193, 265, 10.1016/S0021-9258(19)52451-6

10.1016/0003-2697(79)90738-3

10.1016/0003-2697(82)90118-X

10.1016/0003-2697(68)90092-4

10.1016/S0006-291X(72)80218-3

10.1016/S0076-6879(84)05016-3

Paglia, 1967, Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase, The Journal of laboratory and clinical medicine, 70, 158

10.1016/S0076-6879(85)13062-4

10.1111/1523-1747.ep12506462

10.1371/journal.pone.0158965

Dulai, 2018, Acute severe ulcerative colitis: latest evidence and therapeutic implications, Therapeutic advances in chronic disease, 9, 65, 10.1177/2040622317742095

10.3892/mmr.2017.6241

Takahara, 2019, Berberine improved experimental chronic colitis by regulating interferon-γ-and IL-17A-producing lamina propria CD4+ T cells through AMPK activation, Scientific Reports, 9, 1, 10.1038/s41598-019-48331-w

10.1111/bcpt.12050

10.3389/fphar.2018.00571

10.3389/fimmu.2013.00280

10.1161/01.RES.0000326772.76822.7a

10.2174/13894501113149990157

10.1155/2016/2601830

10.1155/2020/8508906

10.1002/iub.2347

10.1016/j.ejphar.2010.08.046

10.1186/1472-6882-14-49

10.3748/wjg.v23.i2.242

10.1007/BF02893062

10.1016/j.jep.2016.07.055

Albarakati, 2020, Luteolin protects against lead acetate-induced nephrotoxicity through antioxidant, anti-inflammatory, anti-apoptotic, and Nrf2/HO-1 signaling pathways, Molecular Biology Reports, 47, 2591, 10.1007/s11033-020-05346-1

10.1007/s10495-016-1234-5

10.1016/j.intimp.2016.12.031

10.1016/j.biopha.2017.07.101

10.1016/j.molmed.2014.09.006

10.2337/db07-1552

10.1002/mc.22179

10.1038/cdd.2017.14